Productivity & Research

Tempus TIME

AI patient pre-screening connected to an oncology trial network and site activation.

Vendor documentationChecked Oct 12, 2026By AIPicksy Editorial

What it does

AI patient pre-screening connected to an oncology trial network and site activation.

Who it is for

Oncology research centers expanding trial access and matching within a site network.

What stands out

  • LLM and machine-learning clinical-note screening
  • Patient summaries and study insights
  • Just-in-Time trial activation and TIME Precision Network

Limitations to consider

  • A potentially eligible match still requires study screening and consent.
  • Participation depends on site, protocol, and network scope.

Integrations & connections

Tasks it can help with

Sources & verification

This profile is based on vendor documentation, checked Oct 12, 2026. It is not a hands-on review or a performance benchmark. Unknown details are marked explicitly.

Current provider matching and pre-screening productPhase I network and activation scopeSuggest a correction

Read before you decide

0 tools selected for comparison
Tempus TIME: features, pricing & limitations | AIPicksy